Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Guardant Health Inc
(NQ:
GH
)
30.20
-0.30 (-1.00%)
Streaming Delayed Price
Updated: 1:14 PM EDT, Jun 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Guardant Health Inc
< Previous
1
2
3
4
5
6
7
Next >
Benzinga's Top Ratings Upgrades, Downgrades For June 3, 2022
June 03, 2022
Via
Benzinga
10 Biggest Price Target Changes For Monday
May 09, 2022
Morgan Stanley cut Guardant Health, Inc. (NASDAQ: GH) price target from $120 to $85. Guardant Health shares rose 4.3% to $40.99 in pre-market trading.
Via
Benzinga
What 6 Analyst Ratings Have To Say About Guardant Health
May 06, 2022
Over the past 3 months, 6 analysts have published their opinion on Guardant Health (NASDAQ:GH) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
Recap: Guardant Health Q4 Earnings
February 23, 2022
Guardant Health (NASDAQ:GH) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:03 PM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
90 Biggest Movers From Yesterday
May 10, 2022
Gainers
Via
Benzinga
92 Biggest Movers From Friday
May 09, 2022
Gainers Sidus Space, Inc. (NASDAQ: SIDU) jumped 51.8% to settle at $2.99 on Friday after the company announced a a memorandum of understanding with Dhruva Space to expand its partnership to further the...
Via
Benzinga
55 Stocks Moving In Friday's Mid-Day Session
May 06, 2022
Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 24.4% to $7.50. Swvl Holdings 13D Filing from investor Ahmed Sabbah showed a new 6.4% stake in the company.
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
April 07, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Guardant Health's Return On Capital Employed Overview
March 11, 2022
According to data from Benzinga Pro, during Q4, Guardant Health's (NASDAQ:GH) reported sales totaled $108.11 million. Despite a 32.75% increase in earnings, the company posted a...
Via
Benzinga
10 Biggest Price Target Changes For Thursday
February 24, 2022
SVB Leerink lowered Guardant Health, Inc. (NASDAQ: GH) price target from $170 to $140. Guardant Health shares dropped 5.7% to $56.22 in pre-market trading.
Via
Benzinga
The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical Trial, Mainz Biomed Gains On Positive Regulatory Development
February 23, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Kodiak's Wet AMD Treatment KSI-301 Did Not Meet Primary Endpoint In Phase...
Via
Benzinga
Why Jim Cramer Likes Vertiv And Scotts Miracle-Gro
January 07, 2022
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes Vertiv Holdings Co (NYSE:
Via
Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front...
Via
Benzinga
4 Stocks Insiders Are Buying
November 24, 2021
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, t...
Via
Benzinga
68 Biggest Movers From Wednesday
November 26, 2021
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) shares gained 689.4% to settle at $78.94 on Wednesday after the company priced its IPO at $10 per share. Longeveron Inc. (...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
Detecting Early Cancer Screening Stocks At An Early Stage Is Critical
November 22, 2021
If you're going to get cancer, you’re going to want to detect it early. While we’ve come a long way, baby, when it comes to treating terrible maladies like lung...
Via
Benzinga
The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares
November 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus J&J to Separate Its Consumer Health Business Into a New Publicly Traded...
Via
Benzinga
Guardant Health Registers 27% Revenue Growth In Q3, Tops Consensus; Backs FY21 Guidance
November 05, 2021
Guardant Health Inc (NASDAQ: GH) reported Q3 sales of $94.8 million, +27% Y/Y, beating the Wall Street estimate of $92.64 million. Guardant's Q3 precision oncology...
Via
Benzinga
Guardant Health Inc (GH) Q3 2021 Earnings Call Transcript
November 05, 2021
GH earnings call for the period ending October 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Guardant Health: Q3 Earnings Insights
November 04, 2021
Guardant Health (NASDAQ:GH) reported its Q3 earnings results on Thursday, November 4, 2021 at 04:03 PM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
November 04, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &...
Via
Benzinga
Exposures
COVID-19
Guardant Health Will Not Go With NeoGenomics Deal: Bloomberg
October 04, 2021
Guardant Health Inc (NASDAQ: GH) has decided not to pursue a potential acquisition of NeoGenomics Inc (NASDAQ: NEO), Bloomberg reported citing people...
Via
Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...
Via
Benzinga
54 Biggest Movers From Friday
October 04, 2021
Check out these big penny stock gainers and losers Losers Spire Global, Inc.. (NYSE: SPIR) shares fell 43.3% to close at $7.10 on Friday. Spire Global, Inc....
Via
Benzinga
Why Guardant Health Is Down More Than 14% Friday
October 01, 2021
Investors aren't fans of an acquisition the diagnostics company is rumored to be considering.
Via
The Motley Fool
12 Health Care Stocks Moving In Friday's Intraday Session
October 01, 2021
Gainers Biomerica (NASDAQ:BMRA) stock moved upwards by 39.33% to $6.27 during Friday's regular session. As of 12:30 EST, Biomerica's stock is trading at a volume...
Via
Benzinga
Guardant Health Weighing NeoGenomics Acquisition: Bloomberg
October 01, 2021
Bloomberg reported that Guardant Health Inc (NASDAQ: GH) is reportedly exploring an acquisition of NeoGenomics Inc (NASDAQ: NEO), citing people familiar...
Via
Benzinga
Investing in These 2 Top Stocks Could Make You a Millionaire Retiree
September 30, 2021
Both of these companies boast exciting growth prospects.
Via
The Motley Fool
Topics
Retirement
Exposures
Pension
12 Health Care Stocks Moving In Friday's After-Market Session
September 10, 2021
Gainers Hepion Pharmaceuticals (NASDAQ:HEPA
Via
Benzinga
Return on Capital Employed Insights for Guardant Health
September 01, 2021
After pulling data from Benzinga Pro it seems like during Q2, Guardant Health's (NASDAQ:GH) reported sales totaled $92.10 million. Despite a 9.48% in earnings, the company posted...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.